Sobre você

19 A 2018 meta-analysis of observational studies by Corona et al.19 suggested that low baseline endogenous testosterone levels predicted overall and cardiovascular mortality. This finding is consistent with results of the prospective Rotterdam study, which reported an inverse association between testosterone levels in older men and risk and progression of severe aortic atherosclerosis.15 The European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) study, a nested case–control study, similarly reported an inverse relationship between endogenous testosterone concentrations and all-cause mortality and CVD.15 Many population-based studies have found an inverse correlation between endogenous testosterone levels and all-cause and cardiovascular mortality, especially in older men.
The majority of preclinical studies have found testosterone to have vasodilatory effects. Testosterone has a variety of effects on cardiovascular physiology, which may impact the hormone\'s effect on CVD (Fig. 3). In contrast to the use of TRT in hypogonadal men, androgen deprivation therapy (ADT) is commonly used in the treatment of advanced prostate cancer. However, the authors indicated that the data may have been influenced by publication bias.19 A meta-analysis by Araujo et al.20 also found an association between testosterone and overall mortality; however, significant heterogeneity between studies suggested that the effects may have been driven by cohort differences. The longitudinal Cardiovascular Health Study failed to find an association between total and free testosterone levels and either incident CVD or mortality in older men. In contrast, other studies have found no statistically significant association between testosterone level and cardiovascular mortality.
Two retrospective studies of prescription databases showed a higher risk of CV events in men receiving TTh, with the risk increasing early after the treatment was started.11, 12 However, in the paper by Vigen et al.11, it appeared that the initial dataset included women and more than 1000 men were excluded erroneously, leading to the publication of corrections. Concerns about potential adverse effects, such as CV events and prostate health, have fueled ongoing debates and research efforts.6, 7 Testosterone therapy (TTh) has been increasingly recognized as a pivotal intervention in the management of hypogonadism in men, a condition characterized by low levels of serum T accompanied by clinical symptoms such as sexual dysfunction, fatigue, mood disturbances, and low motivation/vitality, anemia, and osteopenia/osteoporosis. Testosterone therapy was found to effectively mitigate anemia in hypogonadal men, highlighting a dual benefit of increasing red blood cell production while managing cardiovascular risks.
Although this new information is somewhat reassuring, men and their doctors should still weigh these issues before committing to long term testosterone therapy. If a man\'s testosterone is below the normal range, it\'s best to repeat it once more to be sure before starting testosterone therapy - often staying on it indefinitely. Agnathans (jawless vertebrates) such as lampreys do not produce testosterone but instead use androstenedione as a male sex hormone. In women with hyperandrogenism, mean levels of total testosterone have been reported to be 62.1 ng/dL. Total levels of testosterone in the body have been reported as 264 to 916 ng/dL (nanograms per deciliter) in non-obese European and American men age 19 to 39 years, while mean testosterone levels in adult men have been reported as 630 ng/dL. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects.
About half of studies have found a relationship and about half, no relationship. have been undertaken on the relationship between more general aggressive behavior, and feelings, and testosterone. This increases the reproductive fitness of the parents because their offspring are more likely to survive and reproduce.|Millions of American men use a prescription testosterone injection or gel as forms of testosterone replacement therapy (often referred to as TRT therapy) to restore normal levels of the manly hormone. When testosterone levels are low, gonadotropin-releasing hormone (GnRH) is released by the hypothalamus, which in turn stimulates the pituitary gland to release FSH and LH. One study found that administering testosterone increased verbal aggression in some participants. The same research found fathers (outside competitive environments) had the lowest testosterone levels compared to other males. Higher testosterone levels in men reduce the risk of becoming or staying unemployed.|Observational studies performed to investigate the association between circulating T concentrations and CVD risk have yielded inconsistent findings. In this article, we review newly published studies evaluating TRT in older men and explore alterations in circulating lipids as one possible mechanism whereby T might influence CVD risk. While meta-analyses of such trials suggest that TRT does not increase CVD risk, a recent randomized trial suggested that TRT might increase risk in certain clinical populations . The best advice is to protect your heart and your body by taking care of known risk factors, such as cholesterol, blood pressure, diabetes, obesity, and tobacco exposure. More research is needed to learn how testosterone affects the heart and the rest of a man\'s body and mind. Cholesterol abnormalities and heart disease were once on that list, but they now appear unlikely.|The opposite directional relationship has also been suggested, such that adiposity may decrease testosterone production. The effect of testosterone on these parameters in various populations has been the subject of debate in many meta-analyses.71 Many trials, including the TOM26 and TTrials,29 have indicated that TRT results in lower total and low-density lipoprotein cholesterol levels. However, due to the nature of the studies, reverse causality cannot be ruled out. Nettleship et al.65 found that testosterone slows atheroma development and reverses lipid deposition in the artery wall.|They observed a baseline prevalence of hypogonadism in this group (by a strict criteria) to be 24%. Even more relevant to the current article is the recently published study by Malkin et al.42 In this study, 930 men with angiographically proven CAD were prospectively followed up over a 7-year period. They found a significant fall in bioavailable testosterone but not total testosterone with age. In a following study, the same group performed a computerized analysis of the Veteran\'s Affair\'s clinical database.69 They looked at 850 men over a 4- to 8-year period controlling for comorbid conditions which would affect mortality, e.g. concurrent cancer. The aforementioned decline in testosterone in some men has previously been regarded by some simply as part of the natural physiology of ageing.|Emerging evidence indicates that congestive heart failure (CHF) is more than just a syndrome affecting a failing heart. Additional research is needed to further evaluate the association between low T levels and CAD severity. In their 2013 review, Oskui and colleagues reported on evidence suggesting that men with lower levels of endogenous T are more likely to develop CAD during their lifetimes.11 The severity of CAD has also been investigated as a function of serum T concentrations. Populations at high risk for TD include men with CHF, type 2 diabetes, obesity, chronic obstructive pulmonary disorder, HIV, and chronic opioid use.7 Testosterone deficiency (TD) is a well-established major medical condition that negatively impacts male sexuality, general health, and quality of life.}

Informações do perfil